Moy P - Search Results

1

MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma.

Bander NH, Yao D, Liu H, Chen YT, Steiner M, Zuccaro W, Moy P. Bander NH, et al. Among authors: moy p. Prostate. 1997 Dec 1;33(4):233-9. doi: 10.1002/(sici)1097-0045(19971201)33:4<233::aid-pros2>3.0.co;2-i. Prostate. 1997. PMID: 9397194

2

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH. Liu H, et al. Among authors: moy p. Cancer Res. 1997 Sep 1;57(17):3629-34. Cancer Res. 1997. PMID: 9288760

3

Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, Navarro V, Rahmati R, Bander NH. Liu H, et al. Among authors: moy p. Cancer Res. 1998 Sep 15;58(18):4055-60. Cancer Res. 1998. PMID: 9751609

4

Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line.

Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. Christiansen JJ, et al. Among authors: moy p. Prostate. 2003 Apr 1;55(1):9-19. doi: 10.1002/pros.10203. Prostate. 2003. PMID: 12640656

5

Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.

Moy PM, Holmes EC, Golub SH. Moy PM, et al. Cancer Res. 1985 Jan;45(1):57-60. Cancer Res. 1985. PMID: 3855286

6

Growth hormone-secreting variants of a mammotropic tumor.

Ito A, Furth J, Moy P. Ito A, et al. Among authors: moy p. Cancer Res. 1972 Jan;32(1):48-56. Cancer Res. 1972. PMID: 5007687 No abstract available.

7

A method for improved yield and purity in extracting lymphocytes from lung tumors.

Moy PM, Holmes EC, Golub SH. Moy PM, et al. J Surg Res. 1985 Jan;38(1):17-23. doi: 10.1016/0022-4804(85)90005-8. J Surg Res. 1985. PMID: 3965805

8

Effects of intralymphatic immunotherapy on natural killer activity in malignant melanoma patients.

Moy PM, Golub SH, Calkins E, Morton DL. Moy PM, et al. J Surg Oncol. 1985 Jun;29(2):112-7. doi: 10.1002/jso.2930290209. J Surg Oncol. 1985. PMID: 4079385

9

Factors affecting survival in superior sulcus tumors.

Anderson TM, Moy PM, Holmes EC. Anderson TM, et al. Among authors: moy pm. J Clin Oncol. 1986 Nov;4(11):1598-603. doi: 10.1200/JCO.1986.4.11.1598. J Clin Oncol. 1986. PMID: 3772415

10

Multihormonal activities of normal and neoplastic pituitary cells as indicated by immunohistochemical staining.

Ueda G, Moy P, Furth J. Ueda G, et al. Among authors: moy p. Int J Cancer. 1973 Jul 15;12(1):100-14. doi: 10.1002/ijc.2910120111. Int J Cancer. 1973. PMID: 4133582 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters